Ken Liu

Ken Liu

Auto-generated profile, based on publicly available information

Ken Liu

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
KLKen H. Liu
Ken H. Liu
MNMary Nellis
Mary Nellis
Karan UppalKaran Uppal
Karan Uppal
CMChunyu Ma
Chunyu Ma
VTViLinh Tran
ViLinh Tran
DJDean P. Jones
Dean P. Jones

1 November 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
MWMichael H. Woodworth
Michael H. Woodworth
RCRoth E. Conrad
Roth E. Conrad
MHMarina Haldopoulos
Marina Haldopoulos
SPStephanie M. Pouch
Stephanie M. Pouch
ABAhmed Babiker
Ahmed Babiker
CKColleen S. Kraft
Colleen S. Kraft
Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation (FMT) can reduce MDRO colonization, but its mechanisms are poorly understood. We conducted a randomized, controlled trial of FMT for MDRO decolonization in renal transplant recipients called PREMIX (NCT02922816). Eleven participants were enrolled and randomized 1:1 to FMT or an observation period followed by delayed FMT if stool cultures were MDRO positive at day 36. Participants who were MDRO positive after one FMT were treated with a second FMT. At last visit, eight of nine patients who completed all treatments were MDRO culture negative. FMT-treated participants had longer time to recurrent MDRO infection versus PREMIX-eligible controls who were not treated with FMT. Key taxa ( Akkermansia muciniphila , Alistipes putredinis , Phocaeicola dorei , Phascolarctobacterium faecium , Alistipes species, Mesosutterella massiliensis , Barnesiella intestinihominis , and Faecalibacterium prausnitzii ) from the single feces donor used in the study that engrafted in recipients and metabolites such as short-chain fatty acids and bile acids in FMT-responding participants uncovered leads for rational microbiome therapeutic and diagnostic development. Metagenomic analyses revealed a previously unobserved mechanism of MDRO eradication by conspecific strain competition in an FMT-treated subset. Susceptible Enterobacterales strains that replaced baseline extended-spectrum β-lactamase–producing strains were not detectable in donor microbiota manufactured as FMT doses but in one case were detectable in the recipient before FMT. These data suggest that FMT may provide a path to exploit strain competition to reduce MDRO colonization.

25 September 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
NCNatacha Colliou
Natacha Colliou
YGYong Ge
Yong Ge
Bikash SahayBikash Sahay
Bikash Sahay
MGMinghao Gong
Minghao Gong
MZMojgan Zadeh
Mojgan Zadeh
MMMansour Mohamadzadeh
Mansour Mohamadzadeh
Consumption of human breast milk (HBM) attenuates the incidence of necrotizing enterocolitis (NEC), which remains a leading and intractable cause of mortality in preterm infants. Here, we report that this diminution correlates with alterations in the gut microbiota, particularly enrichment of Propionibacterium species. Transfaunation of microbiota from HBM-fed preterm infants or a newly identified and cultured Propionibacterium strain, P. UF1, to germfree mice conferred protection against pathogen infection and correlated with profound increases in intestinal Th17 cells. The induction of Th17 cells was dependent on bacterial dihydrolipoamide acetyltransferase (DlaT), a major protein expressed on the P. UF1 surface layer (S-layer). Binding of P. UF1 to its cognate receptor, SIGNR1, on dendritic cells resulted in the regulation of intestinal phagocytes. Importantly, transfer of P. UF1 profoundly mitigated induced NEC-like injury in neonatal mice. Together, these results mechanistically elucidate the protective effects of HBM and P. UF1–induced immunoregulation, which safeguard against proinflammatory diseases, including NEC.

21 May 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
JCJeffrey M. Collins
Jeffrey M. Collins
ASAmnah Siddiqa
Amnah Siddiqa
DJDean P. Jones
Dean P. Jones
KLKen Liu
Ken Liu
RKRussell R. Kempker
Russell R. Kempker
TZThomas Ziegler
Thomas Ziegler
There is limited understanding of the role of host metabolism in the pathophysiology of human tuberculosis (TB). Using high-resolution metabolomics with an unbiased approach to metabolic pathway analysis, we discovered that the tryptophan pathway is highly regulated throughout the spectrum of TB infection and disease. This regulation is characterized by increased catabolism of tryptophan to kynurenine, which was evident not only in active TB disease but also in latent TB infection (LTBI). Further, we found that tryptophan catabolism is reversed with effective treatment of both active TB disease and LTBI in a manner commensurate with bacterial clearance. Persons with active TB and LTBI also exhibited increased expression of indoleamine 2,3-dioxygenase-1 ( IDO-1 ), suggesting IDO-1 mediates observed increases in tryptophan catabolism. Together, these data indicate IDO-1–mediated tryptophan catabolism is highly preserved in the human response to Mycobacterium tuberculosis and could be a target for biomarker development as well as host-directed therapies.

20 December 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
KLKen H. Liu
Ken H. Liu
JOJoshua A. Owens
Joshua A. Owens
BSBejan Saeedi
Bejan Saeedi
CCCatherine E. Cohen
Catherine E. Cohen
MBMoriah P. Bellissimo
Moriah P. Bellissimo
DJDean P. Jones
Dean P. Jones

22 July 2022 in Circulation Research
Verified
Journal Article
Closed access
PDF file
ZLZhen Li
Zhen Li
HXHuijing Xia
Huijing Xia
TSThomas E. Sharp
Thomas E. Sharp
KLKyle B. LaPenna
Kyle B. LaPenna
JEJohn W. Elrod
John W. Elrod
DLDavid Lefer
David Lefer
Background: Hydrogen sulfide (H 2 S) exerts mitochondria-specific actions that include the preservation of oxidative phosphorylation, biogenesis, and ATP synthesis, while inhibiting cell death. 3-MST (3-mercaptopyruvate sulfurtransferase) is a mitochondrial H 2 S-producing enzyme whose functions in the cardiovascular disease are not fully understood. In the current study, we investigated the effects of global 3-MST deficiency in the setting of pressure overload–induced heart failure. Methods: Human myocardial samples obtained from patients with heart failure undergoing cardiac surgeries were probed for 3-MST protein expression. 3-MST knockout mice and C57BL/6J wild-type mice were subjected to transverse aortic constriction to induce pressure overload heart failure with reduced ejection fraction. Cardiac structure and function, vascular reactivity, exercise performance, mitochondrial respiration, and ATP synthesis efficiency were assessed. In addition, untargeted metabolomics were utilized to identify key pathways altered by 3-MST deficiency. Results: Myocardial 3-MST was significantly reduced in patients with heart failure compared with nonfailing controls. 3-MST KO mice exhibited increased accumulation of branched-chain amino acids in the myocardium, which was associated with reduced mitochondrial respiration and ATP synthesis, exacerbated cardiac and vascular dysfunction, and worsened exercise performance following transverse aortic constriction. Restoring myocardial branched-chain amino acid catabolism with 3,6-dichlorobenzo1[b]thiophene-2-carboxylic acid (BT2) and administration of a potent H 2 S donor JK-1 ameliorates the detrimental effects of 3-MST deficiency in heart failure with reduced ejection fraction. Conclusions: Our data suggest that 3-MST derived mitochondrial H 2 S may play a regulatory role in branched-chain amino acid catabolism and mediate critical cardiovascular protection in heart failure.